Drug Class
PARP inhibitor
Type
ingredient
Active Ingredient
olaparib
📋Overview
Olaparib is a medication classified as a PARP inhibitor, which targets specific enzymes involved in DNA repair within cells. It is primarily associated with the management of certain types of cancers, including ovarian, breast, pancreatic, and prostate cancers that have specific genetic mutations. By interfering with cancer cell repair mechanisms, olaparib can help slow the growth and spread of tumors. Its use is often linked to cancers with BRCA gene mutations.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Olaparib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.